Cannabis Science Inc. Receives New Photos and Information on Patient Three’s Previous Examinations and the Current Progress on his Severe Squamous Cell Carcinoma

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to provide the latest photos and information on patient three’s progress.
MORE ON THIS TOPIC